Medicine and Dentistry
Epidermolysis bullosa
66%
Scabies
33%
Permethrin
33%
Benzyl Benzoate
33%
RNA Editing
33%
Drug Repositioning
33%
Transcriptome
33%
DNA RNA Hybridization
33%
Codon
33%
Randomized Controlled Trial
33%
Prematurity
33%
Ribosome
33%
Epidermolysis Bullosa Dystrophica
22%
Squamous Cell Carcinoma
22%
Neoplasm
22%
Artesunate
20%
Atazanavir
20%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
Dermatoscopy
12%
Skin Carcinoma
11%
Organ Transplantation
11%
Selumetinib
11%
Transplantation
11%
Specific Tumor
11%
Immunosuppressive Treatment
11%
Neck
11%
In Silico
11%
Diseases
8%
Clinical Stage
8%
Cas9
8%
Genodermatosis
8%
Quality of Life
8%
Gene Replacement Therapy
8%
Ex Vivo
8%
Luciferase Assay
6%
Kalinin
6%
Ribosome Protein
6%
Dermatosis
6%
Biological Activity
6%
Messenger RNA
6%
Biochemistry, Genetics and Molecular Biology
Epidermolysis bullosa
100%
Exon
41%
Codon
33%
Antisense
33%
Oligonucleotide
33%
Intron
27%
Genetics
23%
Basement Membrane
13%
Genomics
13%
Anchoring Fibrils
13%
Loss of Function Mutation
8%
Microsatellite Marker
8%
Mucosa
8%
Uniparental Disomy
8%
Genotyping
8%
Clobetasol Propionate
8%
Heterozygosity
8%
Homozygosity
8%
Paternity Test
8%
Multiplex Ligation-Dependent Probe Amplification
8%
Copy Number Analysis
8%
Biological Activity
6%
Ribosomal Protein
6%
Drug Dose
6%
Laminin
6%
Messenger RNA
6%
Luciferase
6%
Precursor mRNA
5%
Reverse Transcription Polymerase Chain Reaction
5%
Droplet Digital Polymerase Chain Reaction
5%
Genetic Disorder
5%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermolysis bullosa
66%
microRNA 200b
33%
Epidermolysis Bullosa Dystrophica
33%
Squamous Cell Carcinoma
33%
Psoriasis
33%
Diacerein
33%
Disease
25%
Aminoglycoside
16%
Genodermatosis
16%
Neoplasm
10%
Replacement Therapy
8%
Clobetasol Propionate
8%
Genetic Disorder
8%
Skin Fragility
8%
Ataluren
8%
Aminoglycoside Antibiotic Agent
8%
Gentamicin
8%
Prematurity
8%
Clinical Trial
8%
Injury
8%
microRNA
7%
Cytokine
7%
Dermatitis
7%
